IVOSX | VEVYX | IVOSX / VEVYX | |
Total Expense Ratio | 0.73 | 0.66 | 111% |
Annual Report Gross Expense Ratio | 0.93 | 0.66 | 141% |
Fund Existence | 11 years | 13 years | - |
Gain YTD | 8.882 | 1.133 | 784% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 899M | 17.2B | 5% |
Annual Yield % from dividends | 1.72 | 1.08 | 159% |
Returns for 1 year | 2.19 | -7.20 | -30% |
Returns for 3 years | 9.01 | -2.80 | -322% |
Returns for 5 years | 47.53 | 34.80 | 137% |
Returns for 10 years | 105.72 | 45.03 | 235% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.57 | 0.21 | +0.79% |
First Trust Nasdaq Pharmaceuticals ETF | |||
HACK | 82.90 | 0.47 | +0.57% |
Amplify Cybersecurity ETF | |||
IGBH | 24.48 | 0.06 | +0.25% |
iShares Interest Rate Hdg L/T Corp BdETF | |||
SCDS | 56.45 | N/A | N/A |
JPMorgan Fundamental Data Sci Sm Cor ETF | |||
HIO | 3.94 | -0.02 | -0.51% |
Western Asset High Income Opportunity Fund |